CHRISOVALATOU FARAH: Open Payments
NPI 1134635873 · OCOEE, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$596 in 24 payments from 10 companies in 2025. Trend: 2023 $1,499 · 2024 $931 · 2025 $596
Food & beverage: $596
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 6 | $180 |
| Neurocrine BioSciences, Inc. | 3 | $78 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $73 |
| E.R. Squibb & Sons, L.L.C. | 2 | $50 |
| Otsuka America Pharmaceutical, Inc. | 2 | $48 |
| Lundbeck LLC | 2 | $44 |
| Collegium Pharmaceutical, Inc. | 2 | $39 |
| Bausch Health US, LLC | 2 | $33 |
| Almatica Pharma LLC | 1 | $27 |
| Alkermes, Inc. | 1 | $24 |
Products named: Auvelity, REXULTI, INGREZZA, CAPLYTA, COBENFY, Jornay PM, APLENZIN, LOREEV XR.
Industry payments across FL — which companies pay providers there.
